🇺🇸 FDA

Intelligence Platform

Patents

Browse 3,720 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 8609607

Modified defensins and their use

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Dec 17 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 12 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8609395

Agonist and antagonist peptides of carcinoembryonic antigen (CEA)

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Dec 17 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 12 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8603456

Method of treating hair loss with compositions containing interleukin-1

United Technologies UT AG · Granted Tue Dec 10 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 05 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8604184

Chemically programmable immunity

United States of America as represented by the Secretary of the Air Force · Granted Tue Dec 10 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 05 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8603978

Use of muramyl dipeptide (MDP) for treating inflammation

The United States of America, as represented by the Secretary, Department of Health and Humand Services · Granted Tue Dec 10 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 05 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8603808

Leishmania vaccine using sand fly salivary immunogen

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Dec 10 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 05 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8603468

Neutralization of HCV

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Dec 10 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 05 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8603462

Stem-cell, precursor cell, or target cell-based treatment of multi-organ failure and renal

The United States of America—Department of Veterans Affairs · Granted Tue Dec 10 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 05 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8597660

Therapeutic approach to neurodegenerative disorders using a TFP5-peptide

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Dec 03 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 28 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8597883

Biomarkers for cancer-related fatigue and use thereof

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Dec 03 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 28 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8597876

Method of treating HIV infection

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Dec 03 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 28 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8591889

Human monoclonal antibodies specific for CD22

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Nov 26 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 21 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8586055

DNA immunization protocols

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Nov 19 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 14 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8580927

Engineered antibody constant domain molecules

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Nov 12 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 07 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8580944

Suppressors of CpG oligonucleotides and methods of use

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Nov 12 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 07 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8575375

Androstane and pregnane steroids with potent allosteric GABA receptor chloride ionophore m

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Nov 05 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 31 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8575121

Therapeutic applications of p53 isoforms in regenerative medicine, aging and cancer

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Nov 05 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 31 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8574853

Monoclonal antibodies that neutralize anthrax toxins

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Nov 05 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 31 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8574468

Benzo-fused heterocyclic chromophores for nonlinear optical devices

United States of America as represented by the Secretary of the Air Force · Granted Tue Nov 05 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 31 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8574467

Benzo-fused heterocyclic chromophores for nonlinear optical devices

United States of America as represented by the Secretary of the Air Force · Granted Tue Nov 05 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 31 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8568977

Compositions and methods for diagnosis and treatment of tumors

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Oct 29 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 24 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8569377

Methods for treating spinal cord injury with a compound that inhibits a NCCA-ATP channel

The United States of America as represented by the Department of Veteran Affairs · Granted Tue Oct 29 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 24 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8569028

Method for encapsulation of microparticles

The United States of America, as represented by the Secretary of the Agriculture · Granted Tue Oct 29 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 24 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8568739

Antigenic chimeric tick-borne encephalitis virus/dengue virus type 4 recombinant viruses

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Oct 29 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 24 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted